Editor’s note

India once again made it to the Priority Watch list of the 2015 USTR Special 301 Report, but this year, the reaction from India’s…

As Prime Minister Modi completes a year in office this May, there will no doubt be many lists of this government’s achievements…

As we settle into FY2016, it is worth taking a quick look at some of the earning previews of the last quarter

Success hinges on the company getting its GMP right and surviving the glare of regulatory scrutiny

Finance Minister Arun Jaitley’s first Union Budget had nothing special for the pharmaceutical industry

As in previous years, we mark this Women's Day with a cover story section devoted to women's health issue

The draft National IPR policy, unveiled last December by the Department of Industrial Policy & Promotion (DIPP), has already…

While we are urged to look beyond the sticky issues, one cannot overlook the final impact of decisions on India's IPR policy

CDSCO's planned 'harmonisation of recruitment rules' is sure to resurrect this debate

As the adage goes, look before you leap